Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili’s EndeavorRx shows promise for adults with ADHD.
SteadyMD, AmerisourceBergen partner for pharmacy telehealth and more digital health briefs
